Results 231 to 239 of about 3,331,814 (239)

Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents.

Bioorganic & Medicinal Chemistry Letters, 2015
Rammohan R. Yadav, Sadhana Sharma, Prashant Joshi, A. Wani, R. Vishwakarma, Ajay Kumar, S. Bharate   +6 more
semanticscholar   +1 more source

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Synthetic phenylethanoid glycoside derivatives as potent neuroprotective agents.

European journal of medicinal chemistry, 2015
Ying-Guo Liu, Xiaxi Li, Decai Xiong, Binhan Yu, X. Pu, X. Ye   +5 more
semanticscholar   +1 more source

Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!

Current Pharmaceutical Biotechnology, 2014
M. Daglia, Arianna Di Lorenzo, S. Nabavi, Z. S. Talas, S. Nabavi   +4 more
semanticscholar   +1 more source

Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy.

Journal of Medicinal Chemistry, 2014
S. Woo, Ji Hyun Kim, M. Moon, S. Han, Seul Ki Yeon, J. Choi, Bo Ko Jang, H. Song, Y. Kang, Jin Woo Kim, Jaeick Lee, Dong Jin Kim, O. Hwang, Ki Duk Park   +13 more
semanticscholar   +1 more source

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

Ca-A Cancer Journal for Clinicians, 2009
exaly